China opposes planned U.S. visit by Taiwan vice president

BEIJING (Reuters) – China on Thursday said it firmly opposes any form of official exchange between the United States and Taiwan, and resolutely opposes “sneaky visits” by Taiwan “independence separatists”. China urges the U.S. to stop official U.S.-Taiwan contacts and to stop escalating U.S.-Taiwan “substantive” relations, the foreign ministry said in a statement. Taiwan Vice…

Read More

Cummins misses profit expectations on high manufacturing costs

(Reuters) – Engine maker Cummins reported a second-quarter profit on Thursday that missed analysts’ estimates, hurt by high manufacturing costs. The company’s shares fell 3.8% to $252.20 in premarket trading. Increasing production costs have battered the auto industry’s earnings over the months. Despite taking pricing actions, automakers and parts suppliers have struggled to cover costs…

Read More

In Zimbabwe, a post-Mugabe economic revival remains elusive ahead of vote

By Nyasha Chingono HARARE (Reuters) – When Zimbabwe’s President Emmerson Mnangagwa came to power nearly six years ago after the military toppled long-time ruler Robert Mugabe, he promised to tackle the country’s economic woes “head on”. But for many, like 51-year-old widow Regina Ruona, the promised economic revival remains elusive. After braving a chilly morning…

Read More

Regeneron expects FDA decision on high-dose eye drug this year, shares jump

(Reuters) -Regeneron Pharmaceuticals expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the third quarter, much earlier than market expectations, sending its shares 5% higher in premarket trading on Thursday. The U.S. Food and Drug Administration declined to approve a higher-dose version of Eylea in June following an…

Read More